Correlation Between Champions Oncology and Bright Minds
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Bright Minds Biosciences, you can compare the effects of market volatilities on Champions Oncology and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Bright Minds.
Diversification Opportunities for Champions Oncology and Bright Minds
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Champions and Bright is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Champions Oncology i.e., Champions Oncology and Bright Minds go up and down completely randomly.
Pair Corralation between Champions Oncology and Bright Minds
Given the investment horizon of 90 days Champions Oncology is expected to under-perform the Bright Minds. But the stock apears to be less risky and, when comparing its historical volatility, Champions Oncology is 1.13 times less risky than Bright Minds. The stock trades about -0.22 of its potential returns per unit of risk. The Bright Minds Biosciences is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 3,003 in Bright Minds Biosciences on November 27, 2024 and sell it today you would earn a total of 596.00 from holding Bright Minds Biosciences or generate 19.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Bright Minds Biosciences
Performance |
| Timeline |
| Champions Oncology |
| Bright Minds Biosciences |
Champions Oncology and Bright Minds Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Bright Minds
The main advantage of trading using opposite Champions Oncology and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Bright Minds vs. Revelation Biosciences | Bright Minds vs. Zura Bio Limited | Bright Minds vs. Phio Pharmaceuticals Corp | Bright Minds vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |